Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Eye Co. Medic ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8%   Bankruptcy risk   3.4% 3.3% 3.4% 1.6% 1.8% 1.6% 8.3% 8.2%   Credit score (0-100)   56 56 54 73 71 73 30 30   Credit rating   BBB BBB BBB A A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 18.5 8.1 30.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -1,101 -1,137 -1,143 259 238 32.8 0.0 0.0   EBITDA   -1,101 -1,137 -1,143 259 238 32.8 0.0 0.0   EBIT   -1,322 -1,395 -1,467 -65.5 -660 -57.6 0.0 0.0   Pre-tax profit (PTP)   684.1 1,252.5 3,719.4 2,099.6 4,713.1 3,797.5 0.0 0.0   Net earnings   951.9 1,463.7 4,018.3 2,111.6 4,817.5 3,742.0 0.0 0.0   Pre-tax profit without non-rec. items   684 1,252 3,719 2,100 4,713 3,797 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   1,258 1,772 1,448 1,123 475 0.0 0.0 0.0   Shareholders equity total   8,988 8,452 10,470 10,582 13,399 16,247 12,308 12,308   Interest-bearing liabilities   0.0 0.0 0.0 31.1 1.1 2.6 0.0 0.0   Balance sheet total (assets)   9,021 8,482 11,976 11,125 15,224 18,997 12,308 12,308   Net Debt   -47.1 -8.6 -178 31.1 1.1 2.6 -12,308 -12,308     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -1,101 -1,137 -1,143 259 238 32.8 0.0 0.0   Gross profit growth   0.0% -3.2% -0.5% 0.0% -8.1% -86.2% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   9,021 8,482 11,976 11,125 15,224 18,997 12,308 12,308   Balance sheet change%   -11.3% -6.0% 41.2% -7.1% 36.8% 24.8% -35.2% 0.0%   Added value   -1,101.2 -1,136.6 -1,142.8 259.1 -335.4 32.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -239 255 -649 -649 -1,546 -565 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   120.1% 122.8% 128.4% -25.3% -277.1% -175.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.2% 14.4% 36.4% 19.0% 35.9% 22.3% 0.0% 0.0%   ROI %   7.2% 14.4% 39.4% 20.8% 39.4% 25.8% 0.0% 0.0%   ROE %   10.0% 16.8% 42.5% 20.1% 40.2% 25.2% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   99.6% 99.6% 87.4% 95.1% 88.0% 85.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   4.3% 0.8% 15.6% 12.0% 0.5% 7.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.3% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   814.2% 0.0% 0.0% 580.0% 78.8% 1,353.7% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   169.2 133.8 3.5 13.9 5.0 5.4 0.0 0.0   Current Ratio   169.2 133.8 3.5 13.9 5.0 5.4 0.0 0.0   Cash and cash equivalent   47.1 8.6 177.8 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   5,449.7 3,983.0 3,744.0 7,011.5 7,289.3 12,052.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0